In the News November 29, 2017

The Pink Sheet | Combination Therapies: Incentives Needed To Encourage Labeling Across Products

Marc Scheineson comments on the need for the U.S. Food and Drug Administration to streamline the process for ensuring that drugs used together as part of a treatment regimen are similarly labeled for combination therapy.
Media Contact
Nicholas Clarke
Senior Communications Manager
Phone: 212.210.1222
This website uses cookies to improve functionality and performance. By continuing to browse this site, you are consenting to the use of cookies on this website. For details, see our Privacy Statement